Stay updated with breaking news from Lucent Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lucent Diagnostics, a diagnostics brand of Quanterix Corporation announced expansion of its LucentAD product line with the addition of a high accuracy p-Tau 217 blood test for Alzheimer's disease -...
Agreement provides Quanterix a license to extensively studied p-Tau 217 antibodies to enable global access to plasma-based testing for Alzheimer's Disease research and diagnostics Quanterix Corporation (NASDAQ:QTRX),
New test elevates the performance standard for blood biomarker tests intended for detecting amyloid pathology in individuals with cognitive impairment ...
Qunaterix' LucentAD test could reveal whether a person is likely to have Alzheimer's Disease or not. In an interview with company CEO, Masoud Toloue, he explains the science and motivation behind the test.
Qunaterix' LucentAD test could reveal whether a person is likely to have Alzheimer's Disease or not. In an interview with company CEO, Masoud Toloue, he explains the science and motivation behind the test.